Which is the optimal antiobesity agent for patients with nonalcoholic fatty liver disease?

Overview of attention for article published in Frontiers in endocrinology, September 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Readers on

mendeley: 37 Mendeley

Summary X

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 7,313 followers.

RT @FrontEndocrinol: New Research: Which is the optimal antiobesity agent for patients with nonalcoholic fatty liver disease?: Nonalcoholic…

03 Sep 2022

Reply Repost Favourite

New Research: Which is the optimal antiobesity agent for patients with nonalcoholic fatty liver disease?: Nonalcoholic fatty liver disease (NAFLD) is the commonest chronic liver disease and affects a considerable proportion of the… https://t.co/cwRienY8lg

02 Sep 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.